|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.33 CNY | +1.05% |
|
+1.70% | +1.52% |
Company Valuation: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 32,746 | 50,054 | 38,543 | 26,748 | 28,519 | 28,953 | - | - |
| Change | - | 52.86% | -23% | -30.6% | 6.62% | 1.52% | - | - |
| Enterprise Value (EV) | 32,746 | 49,007 | 39,009 | 25,903 | 28,519 | 28,953 | 28,953 | 28,953 |
| Change | - | 49.66% | -20.4% | -33.6% | 10.1% | 1.52% | 0% | 0% |
| P/E ratio | 24.4x | 21.2x | 28.5x | -36.9x | 22.2x | 19.3x | 16.7x | 13.8x |
| PBR | 3.61x | 4.58x | 3.37x | 2.62x | 2.6x | 2.45x | 2.16x | 1.76x |
| PEG | - | 0.3x | -0.7x | 0x | -0x | 1.1x | 1.1x | 0.7x |
| Capitalization / Revenue | 3.24x | 3.99x | 3.74x | 4.11x | 3.64x | 3.42x | 3.2x | 3.15x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 3.42x | 3.2x | 3.15x |
| EV / EBITDA | 0x | 0x | 0x | -0.06x | 0x | 16.2x | 14.1x | 15.4x |
| EV / EBIT | 0x | 0x | 0x | -0x | 0x | 15.8x | 13.7x | 11x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.3 | 0.5 | 0.3 | - | 0.5 | 0.21 | 0.24 | - |
| Rate of return | 1.53% | 1.67% | 1.3% | - | 2.93% | 1.21% | 1.38% | - |
| EPS 2 | 0.8044 | 1.414 | 0.8095 | -0.4337 | 0.77 | 0.9 | 1.04 | 1.26 |
| Distribution rate | 37.3% | 35.4% | 37.1% | - | 64.9% | 23.3% | 23.1% | - |
| Net sales 1 | 10,117 | 12,533 | 10,318 | 6,513 | 7,831 | 8,472 | 9,043 | 9,188 |
| EBITDA 1 | 1,939 | 3,271 | 2,321 | -0.422 | 2,243 | 1,784 | 2,058 | 1,884 |
| EBIT 1 | 1,569 | 2,830 | 1,780 | -688.9 | 1,623 | 1,835 | 2,112 | 2,628 |
| Net income 1 | 1,344 | 2,362 | 1,352 | -724.5 | 1,286 | 1,509 | 1,737 | 2,098 |
| Net Debt | - | -1,048 | 465.6 | -844.8 | - | - | - | - |
| Reference price 2 | 19.60 | 29.96 | 23.07 | 16.01 | 17.07 | 17.33 | 17.33 | 17.33 |
| Nbr of stocks (in thousands) | 1,670,705 | 1,670,705 | 1,670,705 | 1,670,705 | 1,670,705 | 1,670,705 | - | - |
| Announcement Date | 4/28/22 | 4/25/23 | 4/26/24 | 4/28/25 | 4/27/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 19.26x | - | - | 1.21% | 4.26B | ||
| 15.86x | 1.94x | 12.1x | 5.66% | 13.81B | ||
| 28.88x | 1.69x | 10.44x | 1.82% | 5.59B | ||
| 17.1x | 3.6x | 11.28x | 5.88% | 5.07B | ||
| 28.93x | - | - | - | 4.2B | ||
| 17.55x | 2.24x | 10.03x | 2.43% | 3.28B | ||
| 14.77x | 2.92x | 12.41x | 5.45% | 1.82B | ||
| Average | 20.33x | 2.48x | 11.25x | 3.74% | 5.43B | |
| Weighted average by Cap. | 19.86x | 2.27x | 11.44x | 4.17% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- 002603 Stock
- Valuation Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















